Eptifibatide
- Product NDC
- 70860-303
- 11-digit product format
- 708600303
- Labeler code
- 70860
- Product ID
- 70860-303_e03cf0a7-91aa-4b3c-83e7-393365faa816
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eptifibatide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA213081
- Marketing category
- ANDA
- Marketing start
- 2022-03-21
- Marketing end
- 0000-00-00
- Substance
- EPTIFIBATIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-303-10 | 70860030310 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-303-10) > 10 mL in 1 VIAL, SINGLE-DOSE | 2022-03-21 | 0000-00-00 | No | No | Current |